Abstract
The CB1 cannabinoid receptors are among the most highly expressed G protein coupled receptors (GPCRs) in the brain. Their activation has been associated with a wide range of behaviors, including cognition, pain perception, drug addiction, and memory consolidation, and they have been pharmaceutically targeted for pain therapies, smoking cessation, and appetite control. The CB1 receptor has been challenging to study at the molecular level given the hydrophobic nature of its lipid-based agonists and difficulties expressing the recombinant cDNA in cellular cultures. Early transfection studies in cell cultures revealed predominantly intracellular localization of the CB1 receptor and it was not clear whether this was the “normal” distribution or whether this was some artifact of the cellular model systems. However, studies of the endogenously expressed CB1 receptors using specific antibodies have shown that the there is usually a distinct intracellular, vesicular localization of the CB1 receptor. Confocal microscopy analysis reveals that the intracellular CB1 receptors are localized to vesicles, which implies that the receptors are “trafficking” or undergoing a continuous cycle of internalization and membrane relocalization. The article by McDonald et al. (p. 976) in this issue of Molecular Pharmacology addresses whether this constitutive trafficking is related to the activation state of the receptor and whether it plays a role in axonal versus somatodendritic receptor localization.
Footnotes
-
L.M.B. is funded by the National Institute on Drug Abuse grants DA14600 and DA18860.
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
-
doi:10.1124/mol.107.034223.
-
Please see the related article on page 976.
-
ABBREVIATIONS: AM281, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide.
- Received January 17, 2007.
- Accepted January 24, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|